211-4 Multifunctional Biological Activities of Luteolin and Rosmarinic Acid Isolated From Perilla Frutescens.

Poster Number 298

See more from this Division: C09 Biomedical, Health-Beneficial & Nutritionally Enhanced Plants
See more from this Session: General Biomedical, Health-Beneficial & Nutritionally Enhanced Plants: II
Tuesday, November 2, 2010
Long Beach Convention Center, Exhibit Hall BC, Lower Level
Share |

Tae Joung Ha1, Myoung-Hee Lee2, Chang-Hwan Park2, Kang-Bo Shim2, Suk-Bok Pae2, Chung-Dong Hwang2, Byeong Won Lee1, Chan-Sik Jung1 and Keum-Yong Park2, (1)Dept. of Functional Crop, National Institute of Crop Science, RDA, Miryang, South Korea
(2)National Institute of Crop Science, Rural Development Administration, Milyang, South Korea
Luteolin and rosmarinic acid isolated from the seed of Perilla frutescens (L.) was found to possess preventive antioxidant activities. These two phenolic compounds prevent generation of influenza virions by inhibiting rvH1N1 neuraminidase (EC 3.2.1.18). Notably, the inhibition kinetics analyzed by Dixon plots indicates that luteolin and rosmarinic acid are noncompetitive inhibitor and inhibition constant, Ki, were estimated as 14.3 and 43.9 μM, respectively. Luteolin inhibited the soybean lipoxygenase-1 (EC 1.13.11.12, Type 1) catalyzed oxidation of linoleic acid with an IC50 of 5.0 μM. The inhibition kinetics indicate that luteolin is a simple reversible noncompetitive slow-binding inhibition against soybean lipoxygenase-1 with kinetic parameter (k3 = 0.056 μM-1min-1, k4 = 0.006 μM-1min-1, Kiapp = 0.106 μM). Subsequently, luteolin also inhibited α-glucosidase and recombinant human aldose reductase with IC50 of 45.4 and 0.6 μM, respectively. In the α-glucosidase inhibition kinetics analyzed by Dixon plot indicates that luteolin is a noncompetitive inhibitor, and the inhibition constant, KI was obtained as 45.0 μM. Notably, the inhibition kinetics of luteolin does follow hyperbolic dependence of aldose reductase inhibition on Dixon plots. Thus inhibition kinetics indicated that luteolin is a mixed type inhibitor.
See more from this Division: C09 Biomedical, Health-Beneficial & Nutritionally Enhanced Plants
See more from this Session: General Biomedical, Health-Beneficial & Nutritionally Enhanced Plants: II